Publications by authors named "M Ladekarl"

Claim this Profile
T
The Prognostic Impact of Early ctDNA Kinetics in Metastatic Pancreatic Cancer Using the ctDNA-RECIST.
Mette M Steiniche, Sidsel C Lindgaard, Inna M Chen, Julia S Johansen, Rikke F Andersen, Morten Ladekarl

Clin Cancer Res· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Pembrolizumab treatment of prostate cancer].
Anne Hauge Thostrup, Andreas Carus, Morten Ladekarl, Astrid Johanneson Hjelholt

Ugeskr Laeger· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Characteristics and treatment outcome in a prospective cohort of 639 advanced high-grade digestive neuroendocrine neoplasms (NET G3 and NEC). The NORDIC NEC 2 study.
Halfdan Sorbye, Geir Olav Hjortland, Lene Weber Vestermark, Morten Ladekarl, Johanna Svensson

Br J Cancer· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ABCG2 protein expression in tumors of patients with non-resectable pancreatic cancer treated with gemcitabine and -paclitaxel.
Susy Shim, Mette Bak Nielsen, Mikkel Eld, Jan Stenvang, Rasmus Froberg Brøndum, Morten Ladekarl

Front Oncol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification and validation of a ferroptosis-related long non-coding RNA signature as a prognostic biomarker for hepatocellular carcinoma.
Tingting Yu, Xiaoxiang Chen, Shuo Li, Morten Ladekarl, Jun Li

J Gastrointest Oncol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis